Editorial: Bivalirudin and the Matrix Trial: The End of the Story?

Editorial: Bivalirudin and the Matrix Trial: The End of the Story? Curr Vasc Pharmacol. 2016;14(1):73-5 Authors: De Luca G, Suryapranata H PMID: 26642872 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/26642872?dopt=Abstract

Source: Current Vascular Pharmacology - December 12, 2015 Category: Drugs & Pharmacology Authors: De Luca G, Suryapranata H Tags: Curr Vasc Pharmacol Source Type: research

More News: Angiomax | Drugs & Pharmacology